Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes

This study illustrates the epidemiological applications of Nightingale’s urine panel by identifying novel biomarkers for the future progression of kidney disease in a large cohort of people living with type 1 diabetes.